Abstract

Purpose

To compare different scoring systems for predicting in-hospital mortality in patients with Fournier gangrene (FG).

Methods

A comprehensive literature search was performed to find all scoring systems that have been proposed previously as a predictor for in-hospital mortality in patients with FG. Data of all patients with FG who were hospitalized in one of Indonesia’s largest tertiary referral hospitals between 2012 and 2022 were used. The receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance of the scoring systems.

Results

Ten scoring systems were found, i.e., Fournier’s Gangrene Severity Index (FGSI), Uludag FGSI, simplified FGSI, NUMUNE Fournier score (NFS), Laboratory Risk Indicator for Necrotizing Fasciitis, age-adjusted Charlson comorbidity index, sequential organ failure assessment (SOFA), quick SOFA, acute physiology and chronic health evaluation II, and surgery APGAR score (SAS). Of 164 FG patients included in the analyses, 26.4% died during hospitalization. All scoring systems except SAS could predict in-hospital mortality of patients with FG. Three scoring systems had areas under the ROC curve (AUROC) higher than 0.8, i.e., FGSI (AUROC 0.905, 95% confidence interval (CI) 0.860–0.950), SOFA (AUROC 0.830, 95% CI 0.815–0.921), and NFS (AUROC 0.823, 95% CI 0.739–0.906). Both FGSI and SOFA had sensitivity and NPV of 1.0, whereas NFS had a sensitivity of 0.74 and an NPV of 0.91.

Conclusion

This study shows that FGSI and SOFA are the most reliable scoring systems to predict in-hospital mortality in FG, as indicated by the high AUROC and perfect sensitivity and NPV.

Details

Title
Comparison of different scoring systems for predicting in-hospital mortality for patients with Fournier gangrene
Author
Azmi, Yufi Aulia 1 ; Alkaff, Firas F. 2   VIAFID ORCID Logo  ; Renaldo, Johan 3 ; Wirjopranoto, Soetojo 3 ; Prasetiyanti, Rinta 4 ; Soetanto, Kevin Muliawan 5 ; Salamah, Sovia 6 ; Purba, Abdul Khairul Rizki 7 ; Postma, Maarten J. 8 

 Universitas Airlangga-Dr. Soetomo General Academic Hospital, Department of Urology, Faculty of Medicine, Surabaya, Indonesia (GRID:grid.440745.6) (ISNI:0000 0001 0152 762X); University of Groningen, University Medical Center Groningen, Department of Health Sciences, Groningen, The Netherlands (GRID:grid.4494.d) (ISNI:0000 0000 9558 4598) 
 Faculty of Medicine Universitas Airlangga, Division of Pharmacology and Therapy, Department of Anatomy, Histology, and Pharmacology, Surabaya, Indonesia (GRID:grid.440745.6) (ISNI:0000 0001 0152 762X); University Medical Center Groningen, Division of Nephrology, Department of Internal Medicine, Groningen, The Netherlands (GRID:grid.4494.d) (ISNI:0000 0000 9558 4598) 
 Universitas Airlangga-Dr. Soetomo General Academic Hospital, Department of Urology, Faculty of Medicine, Surabaya, Indonesia (GRID:grid.440745.6) (ISNI:0000 0001 0152 762X) 
 Universitas Airlangga-Dr. Soetomo General Academic Hospital, Department of Clinical Pathology, Faculty of Medicine, Surabaya, Indonesia (GRID:grid.440745.6) (ISNI:0000 0001 0152 762X) 
 Mahidol University, Department of Immunology, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490) 
 University Medical Center Groningen, Division of Nephrology, Department of Internal Medicine, Groningen, The Netherlands (GRID:grid.4494.d) (ISNI:0000 0000 9558 4598); Faculty of Medicine Universitas Airlangga, Department of Public Health and Preventive Medicine, Surabaya, Indonesia (GRID:grid.440745.6) (ISNI:0000 0001 0152 762X) 
 University of Groningen, University Medical Center Groningen, Department of Health Sciences, Groningen, The Netherlands (GRID:grid.4494.d) (ISNI:0000 0000 9558 4598); Faculty of Medicine Universitas Airlangga, Division of Pharmacology and Therapy, Department of Anatomy, Histology, and Pharmacology, Surabaya, Indonesia (GRID:grid.440745.6) (ISNI:0000 0001 0152 762X) 
 University of Groningen, University Medical Center Groningen, Department of Health Sciences, Groningen, The Netherlands (GRID:grid.4494.d) (ISNI:0000 0000 9558 4598); University Medical Center Groningen, University of Groningen, Institute of Science in Healthy Ageing and Healthcare (SHARE), Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); University of Groningen, Unit of Pharmacotherapy, Epidemiology and Economics (PTE2), Department of Pharmacy, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); University of Groningen, Department of Economics, Econometrics and Finance, Faculty of Economics and Business, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981) 
Pages
2751-2757
Publication year
2023
Publication date
Oct 2023
Publisher
Springer Nature B.V.
ISSN
07244983
e-ISSN
14338726
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2878151598
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.